Inhibition of activated/memory (CD45RO+) T cells by oxidative stress associated with block of NF-κB activation1

Journal of Immunology

Volumn 167, Issue 5, 2001, Pages 2595-2601

  Malmberg, K J ^a   Arulampalam, V ^a   Ichihara, F ^a   Petersson, M ^a   Seki, K ^a   Andersson, T ^a   Lenkei, R ^a   Masucci, G ^a   Pettersson, S ^a   Kiessling, R ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; GAMMA INTERFERON; HLA A ANTIGEN; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INTERFERON PRODUCTION; MACROPHAGE ACTIVATION; MEMORY CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

EID: 0035451662     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.5.2595     Document Type: Article

References (53)

1. 2 production during the respiratory burst in alveolar macrophages
2. Respiratory burst in human neutrophils
3. Longitudinal exposure of human T lymphocytes to weak oxidative stress suppresses transmembrane and nuclear signal transduction
4. Oxidative stress suppresses transcription factor activities in stimulated lymphocytes
5. Pre-exposure to oxidative stress decreases the nuclear factor-κB-dependent transcription in T lymphocytes
6. Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex
7. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 ζ chain of T-cell receptor complex and antigen-specific T-cell responses
8. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing ζ molecules and inhibits tumor-specific T cell- and natural killer cellmediated cytotoxicity
9. Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites
10. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway
11. Cytotoxic activity and T cell receptor repertoire in tumor-infiltrating lymphocytes of adrenal cell carcinomas
12. Memory T-lymphocytes are the main population of tumor-infiltrating lymphocytes obtained from human primary liver tumors
13. Human colorectal minor infiltrating lymphocytes express activation markers and the CD45RO molecule, showing a primed population of lymphocytes in the tumor area
14. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1
15. Identification of hydrogen peroxide as the relevant messenger in the activation pathway of transcription factor NF-κB
16. Function and activation of NF-κB in the immune system
17. Activators and target genes of Rel/NF-κB transcription factors
18. Costimulation reverses the defect in IL-2 but not effector cytokine production by T cells with impaired IκBα degradation
19. Interleukin-10 signaling blocks inhibitor of κB kinase activity and nuclear factor κB DNA binding
20. + T lymphocytes specific for HLA class 1-binding peptide epitopes peptideepitopes derived from influenza proteins in the blood of healthy donors and melanoma patients
21. Identification of functional subsets by flow cytometry: Intracellular detection of cytokine expression
22. Determination of the antibody binding capacity of lymphocyte membrane antigens by flow cytometry in 58 blood donors
23. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells
24. Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo
25. Human interleukin-10 can directly inhibit T-cell growth
26. Paradoxical priming effects of IL-10 on cytokine production
27. Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells
28. In vitro immunization and expansion of antigen-specific cytotoxic T lymphocytes for adoptive immunotherapy using peptide-pulsed dendritic cells
29. In vitro priming of tumor-reactive cytolytic T lymphocytes by combining IL-10 with B7-CD28 costimulation
30. Oxidative stress and nuclear factor-κB activation: A reassessment of the evidence in the light of recent discoveries
31. Redox signals and NF-κB activation in T cells
32. Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression
33. Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-κB
34. Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression
35. Immunosuppression in human tumor-host interaction: Role of cytokines and alterations in signal-transducing molecules
36. Delayed hypersensitivity in Hodgkin's disease: A study of 103 untreated patients
37. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors
38. Preferential clonogenic deficit of CD8-positive T-lymphocytes infiltrating human solid tumors
39. Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes
40. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: Correlation with the stage of the disease
41. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: Clinical relevance and effects of cytokine therapy
42. High frequency of cancer patients with abnormal assembly of the T cell receptor-CD3 complex in peripheral blood T lymphocytes
43. Decreased expression of signal-transducing ζ chain in peripheral T cells and natural killer cells in patients with cervical cancer
44. Alterations in NF-κB activation in T lymphocytes of patients with renal cell carcinoma
45. Impaired activation of NF-κB in T cells from a subset of renal cell carcinoma patients is mediated by inhibition of phosphorylation and degradation of the inhibitor, IκBα
46. Absent or low expression of the ζ chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma
47. Clinical significance of decreased ζ chain expression in peripheral blood lymphocytes of patients with head and neck cancer
48. Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer
49. + T lymphocytes in peripheral blood of patients with advanced melanoma
50. Primary chemically induced tumors induce profound immunosuppression concomitant with apoptosis and alterations in signal transduction in T cells and NK cells
51. Caspase-mediated degradation of T-cell receptor ζ-chain
52. Renal cell carcinoma-derived gangliosides suppress nuclear factor-κB activation in T cells
53. Alterations in NF-κB/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy